Deutsche Bank
SNDX icon

Deutsche Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Deutsche Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
74,983
+8,375
+13% +$182K ﹤0.01% 1837
2025
Q4 		$1.4M Sell
66,608
-5,862
-8% -$102K ﹤0.01% 2010
2025
Q3 		$1.12M Buy
72,470
+7,699
+12% +$101K ﹤0.01% 2103
2025
Q2 		$607K Sell
64,771
-139,961
-68% -$1.54M ﹤0.01% 2353
2025
Q1 		$2.52M Buy
204,732
+114,828
+128% +$1.62M ﹤0.01% 1600
2024
Q4 		$1.19M Buy
89,904
+23,634
+36% +$404K ﹤0.01% 2145
2024
Q3 		$1.28M Buy
66,270
+13,081
+25% +$270K ﹤0.01% 2009
2024
Q2 		$1.09M Sell
53,189
-3,086
-5% -$64.6K ﹤0.01% 1945
2024
Q1 		$1.34M Buy
56,275
+7,817
+16% +$174K ﹤0.01% 1861
2023
Q4 		$1.05M Sell
48,458
-1,355
-3% -$20.8K ﹤0.01% 1999
2023
Q3 		$723K Buy
49,813
+6,037
+14% +$114K ﹤0.01% 1926
2023
Q2 		$916K Sell
43,776
-13,368
-23% -$278K ﹤0.01% 2045
2023
Q1 		$1.21M Buy
57,144
+13,559
+31% +$337K ﹤0.01% 1988
2022
Q4 		$1.11M Buy
43,585
+16,705
+62% +$390K ﹤0.01% 1992
2022
Q3 		$646K Sell
26,880
-5,584
-17% -$125K ﹤0.01% 2239
2022
Q2 		$625K Buy
32,464
+1,391
+4% +$23.2K ﹤0.01% 2463
2022
Q1 		$540K Buy
31,073
+990
+3% +$16.7K ﹤0.01% 2701
2021
Q4 		$659K Buy
30,083
+1,366
+5% +$25.2K ﹤0.01% 2669
2021
Q3 		$548K Sell
28,717
-1,736
-6% -$28.9K ﹤0.01% 2962
2021
Q2 		$523K Buy
30,453
+8,035
+36% +$147K ﹤0.01% 3193
2021
Q1 		$501K Buy
22,418
+694
+3% +$15.7K ﹤0.01% 3102
2020
Q4 		$483K Buy
21,724
+6,933
+47% +$144K ﹤0.01% 2930
2020
Q3 		$218K Sell
14,791
-13,587
-48% -$207K ﹤0.01% 3170
2020
Q2 		$421K Buy
28,378
+20,200
+247% +$308K ﹤0.01% 2742
2020
Q1 		$90K Buy
8,178
+424
+5% +$3.98K ﹤0.01% 3299
2019
Q4 		$67K Buy
7,754
+1,375
+22% +$10.1K ﹤0.01% 3800
2019
Q3 		$46K Sell
6,379
-9,854
-61% -$89.8K ﹤0.01% 3979
2019
Q2 		$150K Sell
16,233
-1,864
-10% -$13.6K ﹤0.01% 3999
2019
Q1 		$94K Sell
18,097
-196
-1% -$1.12K ﹤0.01% 4336
2018
Q4 		$81K Sell
18,293
-69,920
-79% -$383K ﹤0.01% 4303
2018
Q3 		$712K Buy
88,213
+50,974
+137% +$363K ﹤0.01% 3561
2018
Q2 		$262K Sell
37,239
-7,264
-16% -$71.3K ﹤0.01% 4164
2018
Q1 		$632K Buy
44,503
+2,228
+5% +$23.6K ﹤0.01% 3586
2017
Q4 		$369K Buy
42,275
+17,213
+69% +$170K ﹤0.01% 3755
2017
Q3 		$290K Sell
25,062
-406
-2% -$4.98K ﹤0.01% 3696
2017
Q2 		$354K Sell
25,468
-7,373
-22% -$84.3K ﹤0.01% 3637
2017
Q1 		$449K Buy
32,841
+30,108
+1,102% +$313K ﹤0.01% 3140
2016
Q4 		$19K Buy
2,733
+1,956
+252% +$21.4K ﹤0.01% 4605
2016
Q3 		$11K Sell
777
-4,796
-86% -$63.1K ﹤0.01% 4653
2016
Q2 		$54K Buy
5,573
+2,584
+86% +$35.4K ﹤0.01% 4377
2016
Q1 		$39K Buy
+2,989
New +$37.6K ﹤0.01% 4407

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Deutsche Bank's SNDX Position: Q1 2026 in Review

Deutsche Bank increased its Syndax Pharmaceuticals (SNDX) stake by 13% in Q1 2026, buying an estimated $182K and bringing the position to 74,983 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Deutsche Bank first reported a position in SNDX in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.52M in Q1 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Deutsche Bank held 74,983 shares of Syndax Pharmaceuticals worth $1.75M as of Q1 2026.
  • Deutsche Bank bought 8,375 Syndax Pharmaceuticals shares in Q1 2026, an estimated $182K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1837 holding.
  • Deutsche Bank first reported a position in Syndax Pharmaceuticals in Q1 2016 and has held it in 41 quarters since.
  • Deutsche Bank's Syndax Pharmaceuticals position peaked at $2.52M in Q1 2025.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.